These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8020119

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Fujii S, Kitano S, Ikenaka K, Fukushima M, Nakamura H, Maehara Y, Shirasaka T.
    Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735
    [Abstract] [Full Text] [Related]

  • 7. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
    Takeshita T, Iwasaki M, Narita M, Sou M, Sato M, Hashimoto T, Kameya S, Iigima N.
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
    Kusama M, Utsunomiya Y, Ono T, Nagura H, Enomoto S.
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats].
    Kuwata K, Nagayama S, Hirakawa Y, Matsushima E, Kawaguchi Y.
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):885-90. PubMed ID: 10897216
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
    Anai H, Maehara Y, Kusumoto H, Kusumoto T, Sugimachi K.
    Oncology; 1988 Jun; 45(3):144-7. PubMed ID: 3130595
    [Abstract] [Full Text] [Related]

  • 12. [Effect of fluoropyrimidine, drugs of tegafur and UFT on transplanted tumor in liver-damaged mice].
    Aoike A, Hosokawa T, Koyama K, Rokutan K, Nishi Y, Yoshida A, Nakamura K, Kawai K.
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2899-905. PubMed ID: 3140731
    [Abstract] [Full Text] [Related]

  • 13. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N, Nitta A, Saitou T, Mori Y, Kunii Y, Kikuchi K.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [Abstract] [Full Text] [Related]

  • 14. [Effect of cepharanthine on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207)--5-fluorouracil delivery into tumor tissue].
    Ono M.
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul 20; 24(7):1379-92. PubMed ID: 2509603
    [Abstract] [Full Text] [Related]

  • 15. Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
    Hanaue H, Kurosawa T, Kitano Y, Miyakawa S, Nemoto A, Yamamoto H, Asagoe T, Takada T, Yasuda H, Shikata J.
    Cancer; 1987 May 01; 59(9):1571-6. PubMed ID: 3103905
    [Abstract] [Full Text] [Related]

  • 16. [Studies on tissue concentration of tegafur, 5-fluorouracil, uracil after UFT administration together with the study of microangiography of colorectal cancer].
    Shimoyama T, Shimizu T, Kusano H, Ishikawa H, Miyashita K, Nakazaki T, Yasutake T, Yoshida A, Yoshida K, Ogawa T.
    Gan To Kagaku Ryoho; 1993 Jan 01; 20(1):125-30. PubMed ID: 8422176
    [Abstract] [Full Text] [Related]

  • 17. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S, Baccanari DP, Joyner SS, Davis ST, Rustum YM, Spector T.
    Cancer Res; 1995 Dec 15; 55(24):6227-30. PubMed ID: 8521418
    [Abstract] [Full Text] [Related]

  • 18. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
    Yamamoto J, Toide K, Haruno A, Yoshimura Y, Unemi N.
    Arzneimittelforschung; 1981 Dec 15; 31(8):1268-78. PubMed ID: 6794578
    [Abstract] [Full Text] [Related]

  • 19. Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Kimura K, Suga S, Shimaji T, Kitamura M, Kubo K, Suzuoki Y, Isobe K.
    Gastroenterol Jpn; 1980 Dec 15; 15(4):324-9. PubMed ID: 6773844
    [Abstract] [Full Text] [Related]

  • 20. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Tomita T, Tajima T, Ishibashi M, Tagaya N, Aoki H, Itoh S, Kadowaki A, Kogure H, Tajima Y.
    Gan To Kagaku Ryoho; 1989 Dec 15; 16(12):3755-62. PubMed ID: 2512859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.